Technology | February 18, 2013

CardioNet, AirStrip Partner to Expand Mobile Patient Monitoring

Integrated mobility solution enables health systems to improve delivery of cardiac care

CardioNet AirStrip Mobility Solution Patient/Remote Monitoring ECG Software

February 18, 2013 — As health systems are under increasing pressure to share data across systems to improve and expand their networks of care, CardioNet Inc. and AirStrip have entered into a partnership agreement to develop and co-market an integrated solution for mobile patient monitoring.

The AirStrip mobility solution will deliver live patient data from CardioNet’s Mobile Cardiac Outpatient Telemetry (MCOT) directly to clinicians’ mobile devices, including tablets and phones. This integrated solution will enable health systems to combine critical cardiac data with electronic medical records (EMR) and device information to improve patient monitoring and clinician decision-making at the point of care.

“This partnership is the foundation for a powerful end-to-end cardiac care package that promises to have a game-changing impact on 30-day readmissions for heart failure,” said Alan Portela, AirStrip CEO. “Our pioneering mobility solution delivers critical patient data to physicians anywhere across the care continuum to encourage better decision-making and improve both the timeliness and quality of care. This integration with CardioNet’s platform enables health systems to empower clinicians with the information they need to achieve key quality metrics in cardiology — one of the most resource and time-intensive practice areas within healthcare.”

While details of the partnership agreement were not disclosed, it is exclusive to select markets. The two companies expect to deliver a market-ready solution by mid-year.

Joseph H. Capper, CardioNet’s president and CEO, commented: “This collaboration is one of the most exciting initiatives CardioNet has embarked on to date. As the leader in the mobile cardiac telemetry market, we are always looking for avenues to expand the utilization of our data. The AirStrip solution is the leading FDA-cleared technology for the transmission of virtual, live ECG waveforms to a healthcare provider’s mobile device. This solution is rapidly transforming the way clinical data is delivered and integrated in a point-of-care setting. Incorporating the timely, accurate information derived from MCOT into AirStrip’s state-of-the-art mobile system will undoubtedly improve the physician’s ability to deliver the proper treatment, the first time.”

For more information: www.cardionet.com, www.airstriptech.com

Related Content

FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Overlay Init